Amgen Inc. Reports Data Incident to Texas Attorney General

Amgen Inc., a leading biotechnology company, has reported a data security incident to the Office of the Texas Attorney General. The company filed its official notification on August 18, 2026, detailing an event that reportedly began on or around July 1, 2026. The full scope and nature of the incident are still under investigation.

The official filing indicates that personal information was involved in this security event. However, specific categories of data that may have been exposed have not been detailed in the public record at this time. Amgen Inc. is known for handling sensitive data related to clinical trials, patient programs, and proprietary research.

While the investigation is ongoing, such incidents involving personal information can carry various risks. These may include heightened exposure to identity theft, phishing attempts, or other forms of fraud. It is important for individuals to understand these potential risks.

If you receive a direct notification from Amgen Inc. regarding this incident, it is important to carefully review the information provided. Consider taking general protective measures such as remaining vigilant for suspicious communications or unexpected account activity. Regularly monitoring your financial statements and credit reports can also help you detect any unauthorized use of your information.

This information is based on public records filed with the Texas Attorney General's office, serving as a factual reference for those seeking to verify details about this reported data breach. The purpose is to provide clear, neutral information drawn directly from official sources.